Identification and functional study of cytokines and chemokines involved in tumorigenesis

Combinatorial Chemistry and High Throughput Screening

Volumn 15, Issue 3, 2012, Pages 276-285

  Zeng, Jun ^a   Xie, Ke ^b   Wu, Hong ^a   Zhang, Boya ^a   Huang, Canhua ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Angiogenesis; Chemokines; Cytokines; Invasion; Metastasis; Tumorigenesis

Indexed keywords

CHEMOKINE; CYTOKINE; POLYPEPTIDE;

ANGIOGENESIS; APOPTOSIS; CANCER INVASION; CARCINOGENESIS; CELL PROLIFERATION; CYTOKINE RELEASE; EPITHELIUM CELL; FIBROBLAST; HUMAN; IMMUNE SYSTEM; LEUKOCYTE; MESENCHYMAL STEM CELL; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; TUMOR CELL;

ANIMALS; CHEMOKINES; CYTOKINES; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE;

EID: 84863272682     PISSN: 13862073     EISSN: 18755402     Source Type: Journal    
DOI: 10.2174/138620712799218608     Document Type: Review

References (120)

1. Burns, J.M.; Summers, B.C.; Wang, Y.; Melikian, A.; Berahovich R.; Miao Z.; Penfold M.E.; Sunshine M.J.; Littman D.R.; Kuo C.J.; Wei K.; McMaster B.E.; Wright K.; Howard M.C.; Schall T.J. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med., 2006, 4, 203(9), 2201-2213.
2. Shurin, G.V.; Ferris, R.L.; Tourkova, I.L.; Perez, L.; Lokshin, A.; Balkir, L.V.; Collins, B.; Chatta, G.S.; Shurin, M.R. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. J. Immunol., 2005, 174(9), 5490-5498. (Pubitemid 40593189)
3. Ozawa, S.; Kato, Y.; Komori, R.; Maehata, Y.; Kubota, E.; Hata, R. BRAK/CXCL14 expression suppresses tumor growth in vivo in human oral carcinoma cells. Biochem. Biophys. Res. Commun., 2006, 22, 348(2), 406-412.
4. Balkwill, F. Cancer and the chemokine network. Nat. Rev. Cancer, 2004, 4(7), 540-550. (Pubitemid 38868623)
5. Jöhrer, K.; Pleyer, L.; Olivier, A.; Maizner, E.; Zelle-Rieser, C.; Greil, R. Tumor-immune cell interactions modulated by chemokines. Expert Opin. Biol. Ther., 2008, 8(3), 269-290. (Pubitemid 351428416)
6. Kucia, M.; Jankowski, K.; Reca, R.; Wysoczynski, M.; Bandura, L.; Allendorf, D.J.; Zhang, J.; Ratajczak, J.; Ratajczak, M.Z. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J. Mol. Histol., 2004, 35(3), 233-245. (Pubitemid 40585309)
7. Dhawan, P.; Richmond, A. Role of CXCL1 in tumorigenesis of melanoma. J. Leukoc. Biol., 2002, 72(1), 9-18.
8. Gomperts, B.N.; Strieter, R.M. Chemokine-directed metastasis. Contrib. Microbiol., 2006, 13, 170-190.
9. Hromas, R.; Broxmeyer, H.E.; Kim, C.; Nakshatri, H.; Christopherson, K 2nd.; Azam, M.; Hou, Y.H. Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem. Biophys. Res. Commun., 1999, 255(3), 703-706.
10. Strieter, R.M.; Burdick, M.D.; Mestas, J.; Gomperts, B.; Keane, M.P.; Belperio, J.A. Cancer CXC chemokine networks and tumor angiogenesis. Eur. J. Cancer, 2006, 42(6), 768-778.
11. Luster, A.D. Chemokines--chemotactic cytokines that mediate inflammation. N. Engl. J. Med., 1998, 338(7), 436-445. (Pubitemid 28135672)
12. Belperio, J.A.; Keane, M.P.; Arenberg, D.A.; Addison, C.L.; Ehlert, J.E.; Burdick, M.D.; Strieter, R.M. CXC chemokines in angiogenesis. J. Leukoc. Biol., 2000, 68(1), 1-8.
13. Strieter, R.M.; Polverini, P.J.; Kunkel, S.L.; Arenberg, D.A.; Burdick, M.D.; Kasper, J.; Dzuiba, J.; Van Damme, J.; Walz, A.; Marriott, D. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem., 1995, 270(45), 27348-27357.
14. Augsten, M.; Hägglöf, C.; Olsson, E.; Stolz, C.; Tsagozis, P.; Levchenko, T.; Frederick, M.J.; Borg, A.; Micke, P.; Egevad, L.; Ostman, A. CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth. Proc. Natl. Acad. Sci., 2009, 106(9), 3414-3419.
15. Orimo, A.; Gupta, P.B.; Sgroi, D.C.; Arenzana-Seisdedos, F.; Delaunay, T.; Naeem, R.; Carey, V.J.; Richardson, A.L.; Weinberg, RA. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell, 2005, 121(3), 335-348. (Pubitemid 40692295)
16. Allinen, M.; Beroukhim, R.; Cai, L.; Brennan, C.; Lahti-Domenici, J.; Huang, H.; Porter, D.; Hu, M.; Chin, L.; Richardson, A.; Schnitt, S.; Sellers, W.R, Polyak, K. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell, 2004, 6(1), 17-32. (Pubitemid 38903159)
17. Yang, G.; Rosen, D.G.; Zhang, Z.; Bast, R.C. Jr.; Mills, G.B.; Colacino, J.A.; Mercado-Uribe, I.; Liu, J. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc. Natl. Acad. Sci., 2006, 103(44), 16472-77164.
18. Frederick, M.J.; Henderson, Y.; Xu, X.; Deavers, M.T.; Sahin, AA.; Wu, H.; Lewis, D.E.; El-Naggar, A.K.; Clayman, G.L. In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am J. Pathol., 2000, 156(6), 1937-1950. (Pubitemid 30641763)
19. Kleer, C.G.; Bloushtain-Qimron, N.; Chen, Y.H.; Carrasco, D.; Hu, M.; Yao, J.; Kraeft, S.K.; Collins, L.C.; Sabel, M.S.; Argani, P.; Gelman, R.; Schnitt, S.J.; Krop, I.E.; Polyak, K. Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression. Clin. Cancer Res., 2008, 14(17), 5357-5367.
20. Murdoch, C.; Finn, A. Chemokine receptors and their role in inflammation and infectious diseases. Blood, 2000, 95(10), 3032- 3043.
21. Chuntharapai, A.; Lee, J.; Hébert, C.A.; Kim, K.J. Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J. Immunol., 1994, 153(12), 5682-5688. (Pubitemid 24377704)
22. Loetscher, M.; Gerber, B.; Loetscher, P.; Jones, S.A.; Piali, L.; Clark-Lewis, I.; Baggiolini, M.; Moser, B. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med., 1996, 184(3), 963-969. (Pubitemid 26313554)
23. Taub, D.D.; Lloyd, A.R.; Conlon, K.; Wang, J.M.; Ortaldo, J.R.; Harada, A.; Matsushima, K.; Kelvin, D.J.; Oppenheim, J.J. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med., 1993, 177(6), 1809-1814. (Pubitemid 23146150)
24. Liao, F.; Rabin, R.L.; Yannelli, J.R.; Koniaris, L.G.; Vanguri, P.; Farber, J.M. Human Mig chemokine: biochemical and functional characterization. J. Exp. Med., 1995, 182(5), 1301-1314.
25. Bazan, J.F.; Bacon, K.B.; Hardiman, G.; Wang, W.; Soo, K.; Rossi, D.; Greaves, D.R.; Zlotnik, A.; Schall, T.J. A new class of membrane-bound chemokine with a CX3C motif. Nature, 1997, 385(6617), 640-644.
26. Fong, A.M.; Robinson, L.A.; Steeber, D.A.; Tedder, T.F.; Yoshie, O.; Imai, T.; Patel, D.D. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med., 1998, 188(8), 1413-1419. (Pubitemid 28489578)
27. Kanazawa, N.; Nakamura, T.; Tashiro, K.; Muramatsu, M.; Morita, K.; Yoneda, K.; Inaba, K.; Imamura, S.; Honjo, T. Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells. Eur. J. Immunol., 1999, 29(6), 1925-1932. (Pubitemid 29265548)
28. Daugherty, BL.; Siciliano, S.J.; DeMartino, J.A.; Malkowitz, L.; Sirotina, A.; Springer, M.S. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J. Exp. Med., 1996, 183(5), 2349-2354. (Pubitemid 26158926)
29. Uguccioni, M.; Mackay, C.R.; Ochensberger, B.; Loetscher, P.; Rhis, S.; LaRosa, G.J.; Rao, P.; Ponath, P.D.; Baggiolini, M.; Dahinden, C.A. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J. Clin. Invest., 1997, 100(5), 1137-1143. (Pubitemid 27386297)
30. Forssmann, U.V.; Uguccioni, M.; Loetscher, P.; Dahinden, C.A.; Langen, H.; Thelen, M.; Baggiolini, M. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J. Exp. Med., 1997, 185(12), 2171-2176. (Pubitemid 27266000)
31. Schall, T.J.; Bacon, K.B. Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol., 1994, 6(6), 865-8673.
32. Wolpe, S.D.; Cerami, A. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J., 1989, 3(14), 2565-2573. (Pubitemid 20013270)
33. Murphy, P.M. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol., 1994, 12, 593-633. (Pubitemid 24140426)
34. Feng, Y.; Broder, C.C.; Kennedy, P.E.; Berger, E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science, 1996, 272(5263), 872-877. (Pubitemid 26154590)
35. Dragic, T.; Litwin, V.; Allaway, G.P.; Martin, S.R.; Huang, Y.; Nagashima, K.A.; Cayanan, C.; Maddon, P.J.; Koup, R.A.; Moore, J.P.; Paxton, W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature, 1996, 381(6584), 667- 673.
36. Alkhatib, G.; Combadiere, C.; Broder, C.C.; Feng, Y.; Kennedy, P.E.; Murphy, P.M.; Berger, E.A. CC CKR5: a RANTES, MIP- 1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science, 1996, 272(5270), 1955-1958. (Pubitemid 26234510)
37. Doranz, B.J.; Rucker, J.; Yi, Y.; Smyth, R.J.; Samso, M.; Peiper, S.C.; Parmentier, M.; Collman, R.G.; Doms, R.W. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell, 1996, 85(7), 1149-1158. (Pubitemid 26235280)
38. Wells, T.N.; Proudfoot, A.E. Chemokine receptors and their antagonists in allergic lung disease. Inflamm. Res., 1999, 48(7), 353-362. (Pubitemid 29361244)
39. Yamamoto, J.; Adachi, Y.; Onoue, Y.; Kanegane, H.; Miyawaki, T.; Toyoda, M.; Seki, T.; Morohashi, M. CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis. Allergy, 2000, 55(11), 1011-1018.
40. Mach, F. The role of chemokines in atherosclerosis. Curr. Atheroscler Rep., 2001, 3(3), 243-251.
41. Tkachuk, A.N.; Moormann, A.M.; Poore, J.A.; Rochford, R.A.; Chensue, S.W.; Mwapasa, V.; Meshnick, S.R. Malaria enhances expression of CC chemokine receptor 5 on placental macrophages. J. Infect. Dis., 2001, 183(6), 967-972. (Pubitemid 32207067)
42. Loetscher, P.; Moser, B.; Baggiolini, M. Chemokines and their receptors in lymphocyte traffic and HIV infection. Adv. Immunol., 2000, 74, 127-180.
43. Zlotnik, A.; Morales, J.; Hedrick, J.A. Recent advances in chemokines and chemokine receptors. Crit. Rev. Immunol., 1999, 19(1), 1-47. (Pubitemid 29062100)
44. Baggiolini, M.; Dewald, B.; Moser, B. Human chemokines: an update. Annu. Rev. Immunol., 1997, 15, 675-705. (Pubitemid 27169296)
45. Ren, F.; Wu, H.; Lei, Y.; Zhang, H.; Liu, R.; Zhao, Y.; Chen, X.; Zeng, D.; Tong, A.; Chen, L.; Wei, Y.; Huang, C. Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma. Mol. Cancer, 2010, 9, 81.
46. Murphy, P.M. Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev., 1996, 7(1), 47-64. (Pubitemid 27202665)
47. Bokoch, G.M. Chemoattractant signaling and leukocyte activation. Blood, 1995, 86(5), 1649-2660.
48. Wu, D.; LaRosa, G.J.; Simon, M.I. G protein-coupled signal transduction pathways for interleukin-8. Science, 1993, 261(5117), 101-103. (Pubitemid 23265387)
49. Kuang, Y.; Wu, Y.; Jiang, H.; Wu, D. elective G protein coupling by C-C chemokine receptors. J. Biol. Chem., 1996, 271(8), 3975- 3978.
50. Bacon, K.B.; Szabo, M.C.; Yssel, H.; Bolen, J.B.; Schall, T.J. RANTES induces tyrosine kinase activity of stably complexed p125FAK and ZAP-70 in human T cells. J. Exp. Med., 1996, 184(3), 873-882.
51. Kampen, G.T.; Stafford, S.; Adachi, T.; Jinquan, T.; Quan, S.; Grant, J.A.; Skov, P.S.; Poulsen, L.K.; Alam, R. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood, 2000, 95(6), 1911-1917. (Pubitemid 30151625)
52. Wang, B.; Hendricks, D.T.; Wamunyokoli, F.; Parker, M.I. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer. Cancer Res., 2006, 66(6), 3071-3077.
53. Burger, M.; Hartmann, T.; Burger, J.A.; Schraufstatter, I. KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway. Oncogene, 2005, 24(12), 2067-2075. (Pubitemid 40516200)
54. Dhawan, P.; Richmond, A. Role of CXCL1 in tumorigenesis of melanoma. J Leukoc. Biol., 2002, 72(1), 9-18.
55. Bodart, J.F. Extracellular-regulated kinase-mitogen-activated protein kinase cascade: unsolved issues. J. Cell. Biochem., 2010, 109(5), 850-857.
56. Pradom G.N.; Suetomim K.; Shumatem D.; Maxwellm C.; Ravindranm A.; Rajarathnamm K.; Navarrom J. Chemokine signaling specificity: essential role for the N-terminal domain of chemokine receptors. Biochemistry, 2007, 46(31), 8961-8968.
57. Friedmanm A.; Perrimonm N. A functional RNAi screen for regulators of receptor tyrosine kinase and ERK signalling. Nature, 2006, 444(7116), 230-234.
58. Xiam M.; Hymanm B.T. GROalpha/KC, a chemokine receptor CXCR2 ligand, can be a potent trigger for neuronal ERK1/2 and PI-3 kinase pathways and for tau hyperphosphorylation-a role in Alzheimer's disease? J. Neuroimmunol., 2002, 122(1-2), 55-64.
59. Zhao, M.; Wimmer, A.; Trieu, K.; Discipio, R.G.; Schraufstatter, I.U. Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2. J. Biol. Chem., 2004, 279(47), 49259-49267. (Pubitemid 39625811)
60. Israël, A. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb. Perspect. Biol., 2010, 2(3), a000158.
61. Leelawat, K.; Leelawat, S.; Narong, S.; Hongeng, S. Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion. World J. Gastroenterol., 2007, 13(10), 1561-1568. (Pubitemid 46672665)
62. Zheng, H.; Fu, G.; Dai, T.; Huang, H. Migration of endothelial progenitor cells mediated by stromal cell-derived factor- 1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J. Cardiovasc. Pharmacol., 2007, 50(3), 274-2780.
63. Liang, Z.; Brooks, J.; Willard, M.; Liang, K.; Yoon, Y.; Kang, S.V.; Shim H. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem. Biophys. Res. Commun., 2007, 359(3), 716-722. (Pubitemid 46908803)
64. Rückle, T.; Schwarz, M.K.; Rommel, C. PI3Kgamma inhibition: towards an 'aspirin of the 21st century? Nat. Rev. Drug Discov., 2006, 5(11), 903-918.
65. Bader, A.G.; Kang, S.; Zhao, L.; Vogt, P.K. Oncogenic PI3K deregulates transcription and translation. Nat. Rev. Cancer, 2005, 5(12), 921-929. (Pubitemid 41766781)
66. Yan, W.; Chen, X. Identification of GRO1 as a critical determinant for mutant p53 gain of function. J. Biol. Chem., 2009, 284(18), 12178-12187.
67. Opdenakker, G.; Van Damme, J. Chemokines and proteinases in autoimmune diseases and cancer. Verh. K. Acad. Geneeskd. Belg., 2002, 64(2), 105-136.
68. Yoshida, D.; Nomura, R.; Teramoto, A. Signaling pathway mediated by CXCR7, an alternative chemokine receptor for stromal-cell derived factor-1alpha, in AtT20 mouse ACTH-secreting pituitary adenoma cells. J. Neuroendocrinol., 2009, 21(5), 481-488.
69. Bergers, G.; Benjamin, L.E. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer, 2003 3(6), 401-410. (Pubitemid 37328844)
70. Strieter, R.M.; Burdick, M.D.; Gomperts, B.N.; Belperio, J.A.; Keane, M.P. CXC chemokines in angiogenesis. Cytokine Growth Factor Rev. 2005 16(6), 593-609. (Pubitemid 41505519)
71. Strieter R.M.; Belperio J.A.; Phillips R.J.; Keane M.P. CXC chemokines in angiogenesis of cancer. Semin. Cancer Biol., 2004, 14(3), 195-200. (Pubitemid 38586745)
72. Keane, M.P.; Belperio, J.A.; Xue, Y.Y.; Burdick, M.D.; Strieter, R.M. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J. Immunol., 2004, 172(5), 2853-2860. (Pubitemid 38263670)
73. Nör, J.E.; Christensen, J.; Liu, J.; Peters, M.; Mooney, D.J.; Strieter, R.M.; Polverini, P.J. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res., 2001, 61(5), 2183- 2188.
74. Heidemann, J.; Ogawa, H.; Dwinell, M.B.; Rafiee, P.; Maaser, C.; Gockel, H.R.; Otterson, M.F.; Ota, D.M.; Lugering, N.; Domschke, W.; Binion, D.G. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J. Biol. Chem., 2003, 278(10), 8508-8515. (Pubitemid 36800603)
75. Struyf, S.; Burdick, M.D.; Proost, P.; Van Damme, J.; Strieter, R.M. Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis. Circ. Res., 2004, 95(9), 855-857.
76. Maione, T.E.; Gray, GS.; Petro, J.; Hunt, A.J.; Donner, A.L.; Bauer, S.I.; Carson, H.F.; Sharpe, R.J. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science, 1990, 247(4938), 77-79.
77. Bachelder, R.E.; Wendt, M.A.; Mercurio, A.M. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer. Res., 2002, 62(24), 7203-7206. (Pubitemid 36025239)
78. Salcedo, R.; Oppenheim, J.J. Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses. Microcirculation, 2003, 10(3-4), 359-370. (Pubitemid 39004262)
79. Kijowski, J.; Baj-Krzyworzeka, M.; Majka, M.; Reca, R.; Marquez, L.A.; Christofidou-Solomidou, M.; Janowska-Wieczorek, A.; Ratajczak, M.Z. The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Stem Cells, 2001, 19(5), 453466.
80. Salcedo, R.; Wasserman, K.; Young, H.A.; Grimm, M.C.; Howard, O.M.; Anver, M.R.; Kleinman, H.K.; Murphy, W.J.; Oppenheim, J.J. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. Am. J. Pathol., 1999, 154(4), 1125-1135. (Pubitemid 29169747)
81. Schrader, A.J.; Lechner, O.; Templin, M.; Dittmar, KE.; Machtens, S.; Mengel, M.; Probst-Kepper, M.; Franzke, A.; Wollensak, T.; Gatzlaff, P.; Atzpodien, J.; Buer, J.; Lauber, J. CXCR4/CXCL12 expression and signalling in kidney cancer. Br. J. Cancer, 2002, 86(8), 1250-1256.
82. Müller, A.; Homey, B.; Soto, H.; Ge, N.; Catron, D.; Buchanan, M.E.; McClanahan, T.; Murphy, E.; Yuan, W.; Wagner, S.N.; Barrera, J.L.; Mohar, A.; Verástegui, E.; Zlotnik, A. Involvement of chemokine receptors in breast cancer metastasis. Nature, 2001, 410(6824), 50-56. (Pubitemid 32225831)
83. Fulmer T.; Writer, S. Targeting chemokines in breast cancer. SciBX 2010, 3(4).
84. Visvader, J.E.; Lindeman, G.J. Cancer stem cells in solid tumors: accumulating evidence and unresolved questions. Nat. Rev. Cancer, 2008, 8(10), 755-768.
85. Kern, S.E.; Kinzler, K.W.; Bruskin, A.; Jarosz, D.; Friedman, P.; Prives, C.; Vogelstein, B. Identification of p53 as a sequence-specific DNA-binding protein. Science, 1991, 252(5013), 1708- 1711.
86. Hacke, K.; Rincon-Orozco, B.; Buchwalter, G.; Siehler, S.Y.; Wasylyk, B.; Wiesmüller L.; Rösl F. Regulation of MCP-1 chemokine transcription by p53. Mol. Cancer, 2010, 9, 82.
87. Mantovani, A.; Allavena, P.; Sozzani, S.; Vecchi, A.; Locati, M.; Sica, A. Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. Semin. Cancer Biol., 2004, 14(3), 155-160. (Pubitemid 38586740)
88. Balkwill, F. Cancer and the chemokine network. Nat. Rev. Cancer, 2004, 4(7), 540-550. (Pubitemid 38868623)
89. Ben-Baruch A. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev., 2006, 25(3), 357-371. (Pubitemid 44922355)
90. Zipin-Roitman, A.; Meshel, T.; Sagi-Assif, O.; Shalmon, B.; Avivi, C.; Pfeffer, R.M.; Witz, I.P.; Ben-Baruch, A. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res., 2007, 67(7), 3396-3405. (Pubitemid 46724880)
91. Li, G.; Tian, L.; Hou, J.M.; Ding, Z.Y.; He, Q.M.V.; Feng, P.; Wen, Y.J.; Xiao, F.; Yao, B.; Zhang, R.; Peng, F.; Jiang, Y.; Luo, F.; Zhao, X.; Zhang, L.; Zhou, Q.; Wei, Y.Q. Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors. Clin. Cancer Res., 2005, 11(11), 4217-4224.
92. Maksym, R.B.; Tarnowski, M.; Grymula, K.; Tarnowska, J.; Wysoczynski, M.; Liu, R.; Czerny, B.; Ratajczak, J.; Kucia, M.; Ratajczak, M.Z. The role of stromal-derived factor-1 - CXCR7 axis in development and cancer. Eur. J. Pharmacol., 2009, 625(1-3), 31-40.
93. Zlotnik, A. Chemokines in neoplastic progression. Semin. Cancer Biol., 2004, 14(3), 181-185. (Pubitemid 38586743)
94. Witz I.P. Presence and functions of immune components in the tumor microenvironment. Adv. Exp. Med. Biol., 2001, 495:317- 324.
95. Menon, A.G.; Janssen-van Rhijn, C.M.; Morreau, H.; Putter, H.; Tollenaar, R.A.; van de Velde, C.J.; Fleuren, G.J.; Kuppen, P.J. Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis. Lab. Invest., 2004, 84(4), 493-501. (Pubitemid 41656477)
96. Chiba, T.; Ohtani, H.; Mizoi, T.; Naito, Y.; Sato, E.; Nagura, H.; Ohuchi, A.; Ohuchi, K.; Shiiba, K.; Kurokawa, Y.; Satomi, S. Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis. Br. J. Cancer, 2004, 91(9), 1711-1717. (Pubitemid 39546145)
97. Pagès, F.; Berger, A.; Camus, M.; Sanchez-Cabo, F.; Costes, A.; Molidor, R.; Mlecnik, B.; Kirilovsky, A.; Nilsson, M.; Damotte, D.V.; Meatchi, T.; Bruneval, P.; Cugnenc, P.H.; Trajanoski, Z.; Fridman, W.H.; Galon, J. Effector memory T cells, early metastasis, and survival in colorectal cancer. N. Engl. J. Med., 2005, 353(25), 2654-2666. (Pubitemid 41817714)
98. Singh, U.P.; Singh, S.; Iqbal, N.; Weaver, C.T.; McGhee, J.R.; Lillard, J.W. Jr. IFN-gamma-inducible chemokines enhance adaptive immunity and colitis. J. Interferon Cytokine. Res., 2003, 23(10), 591-600.
99. Neville, L.F.; Mathiak, G.; Bagasra, O. The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily. Cytokine Growth Factor Rev., 1997, 8(3), 207-219. (Pubitemid 28077928)
100. Lazzeri, E.; Romagnani, P. CXCR3-binding chemokines: novel multifunctional therapeutic targets. Curr. Drug Targets. Immune. Endocr. Metabol. Disord., 2005, 5(1), 109-118. (Pubitemid 40394308)
101. Strieter, R.M.; Burdick, M.D.; Mestas, J.; Gomperts, B.; Keane, M.P.; Belperio, J.A. Cancer CXC chemokine networks and tumor angiogenesis. Eur. J. Cancer, 2006, 42(6), 768-778.
102. Sleeman, M.A.; Fraser, J.K.; Murison, J.G.; Kelly, S.L.; Prestidge, R.L.; Palmer, D.J.; Watson, J.D.; Kumble, K.D. B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR alpha-chemokine. Int. Immunol., 2000, 12(5), 677-669.
103. Cao, X.; Zhang, W.; Wan, T.; He, L.; Chen, T.; Yuan, Z.; Ma, S.; Yu, Y.; Chen, G. Molecular cloning and characterization of a novel CXC chemokine macrophage inflammatory protein-2 gamma chemoattractant for human neutrophils and dendritic cells. J. Immunol., 2000, 165(5), 2588-2595. (Pubitemid 30660705)
104. Frederick, M.J.; Henderson, Y.; Xu, X.; Deavers, M.T.; Sahin, A.A.; Wu, H.; Lewis, D.E.; El-Naggar, A.K.; Clayman, G.L. In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am. J. Pathol., 2000, 156(6), 1937-1950. (Pubitemid 30641763)
105. Kurth, I.; Willimann, K.; Schaerli, P.; Hunziker, T.; Clark-Lewis, I.; Moser, B. Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J. Exp. Med., 2001, 194(6), 855-861. (Pubitemid 32983020)
106. Shurin, G.V.; Ferris, R.L.; Tourkova, I.L.; Perez, L.; Lokshin, A.; Balkir, L.; Collins, B.; Chatta, G.S.; Shurin, M.R. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. J. Immunol., 2005, 174(9), 5490-5498. (Pubitemid 40593189)
107. Starnes, T.; Rasila, K.K.; Robertson, M.J.; Brahmi, Z.; Dahl, R.; Christopherson, K.; Hromas, R. The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy. Exp. Hematol., 2006, 34(8), 1101-1105. (Pubitemid 44080391)
108. Balkwill, F.; Mantovani, A. Inflammation and cancer: back to Virchow? Lancet, 2001, 357(9255), 539-545. (Pubitemid 32173595)
109. Pollard, J.W. Tumor-educated macrophages promote tumor progression and metastasis. Nat. Rev. Cancer, 2004, 4(1), 71-78. (Pubitemid 38082155)
110. Lin, E.Y.; Pollard, J.W. Macrophages: modulators of breast cancer progression. Novartis Found Symp., 2004, 256,158-168.
111. Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature, 2002, 420(6917), 860-867. (Pubitemid 36019639)
112. de Visser, K.E.; Eichten, A.; Coussens, L.M. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer, 2006, 6(1), 24-37. (Pubitemid 43053650)
113. Biswas, S.K .; Gangi, L.; Paul, S.; Schioppa, T.; Saccani, A.; Sironi, M.; Bottazzi, B.; Doni, A.; Vincenzo, B.; Pasqualini, F.; Vago, L.; Nebuloni, M.; Mantovani, A.; Sica, A. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). Blood, 2006, 107(5), 2112-2122. (Pubitemid 43289397)
114. Murdoch, C.; Muthana, M.; Lewis, C.E. Hypoxia regulates macrophage functions in inflammation. J. Immunol., 2005, 175(10), 6257-6263. (Pubitemid 41598863)
115. Egeblad, M.; Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2002, 2(3), 161-174. (Pubitemid 37328786)
116. Sawano, A.; Iwai, S.; Sakurai, Y.; Ito, M.; Shitara, K.; Nakahata, T.; Shibuya, M. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood, 2001, 97(3), 785-791. (Pubitemid 32113414)
117. Barleon, B.; Sozzani, S.; Zhou, D.; Weich, H.A.; Mantovani, A.; Marmé, D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood, 1996, 87(8), 3336-3343. (Pubitemid 26115364)
118. Clauss, M.; Weich, H.; Breier, G.; Knies, U.; Röckl, W.; Waltenberger, J.; Risau, W. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem., 1996, 271(30), 17629-17634. (Pubitemid 26250731)
119. Kawanishi, H.; Matsui, Y.; Ito, M.; Watanabe, J.; Takahashi, T.; Nishizawa, K.; Nishiyama, H.; Kamoto, T.; Mikami, Y.; Tanaka, Y.; Jung, G.; Akiyama, H.; Nobumasa, H.; Guilford, P.; Reeve, A.; Okuno, Y.; Tsujimoto, G.; Nakamura, E.; Ogawa, O. Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer. Clin. Cancer. Res., 2008, 14(9), 2579-2587.
120. Reckamp, K.L.; Figlin, R.A.; Burdick, M.D.; Dubinett, S.M.; Elashoff, R.M.; Strieter, R.M. CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer. BMC Cancer, 2009, 9, 213.